Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL
In all urbanized countries, more than half of overall mortality is conditioned by diseases caused by atherothrombosis in the arteries of heart and brain. In Russia, as compared with Europe and the United States, the mortality rate is 3-5 times higher. The key factors that in many countries contribut...
Main Author: | NA Mazur |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/690 |
Similar Items
-
Antiaggregants in cardiology: choice of best individual treatment
by: A. N. Yakovlev
Published: (2015-12-01) -
Role of clopidogrel role in secondary prevention of ischemic stroke
by: K. S. Meshkova, et al.
Published: (2014-12-01) -
Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01) -
ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY
by: V. V. Yakusevich, et al.
Published: (2014-07-01) -
ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY
by: V. V. Yakusevich, et al.
Published: (2014-07-01)